- Enrolling by invitationPHASE3
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
This study looks at a medicine called vutrisiran for a heart condition called transthyretin amyloidosis (ATTR cardiomyopathy). It aims to understand how safe and effective vutrisiran is for patients who have already been taking it or switched from a similar medicine called patisiran.
For: Transthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States · Argentina · Austria - Active not recruitingPHASE3
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
This study is looking at a new medicine called vutrisiran for people with a heart condition called transthyretin amyloidosis (ATTR) cardiomyopathy. It aims to see if the medicine can help improve the condition and if it's safe compared to a dummy treatment.
For: Transthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States · Argentina · Australia